Clinical Trials
13
Active:11
Completed:2
Trial Phases
1 Phases
Phase 1:7
Drug Approvals
10
CIMA_AEMPS:9
SFDA:1
Drug Approvals
ABIRATERONA STRAGEN 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
- Approval Date
- Jul 14, 2025
CIMA_AEMPS
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Phase 1
7 (100.0%)First-In-Human PainCart Study for STR-324
Phase 1
Completed
- Conditions
- Pain
- Interventions
- Drug: PlaceboDrug: STR-324 Dose Level ADrug: STR-324 Dose Level BDrug: STR-324 Dose Level CDrug: STR-324 Dose Level 1Drug: STR-324 Dose Level 2Drug: STR-324 Dose Level 3Drug: STR-324 Dose Level 4Drug: STR-324 Dose Level 5Drug: STR-324 Dose Level 6Drug: STR-324 Dose Level 7Drug: STR-324 Dose Level 8
- First Posted Date
- 2018-02-12
- Last Posted Date
- 2018-12-12
- Lead Sponsor
- Stragen France
- Target Recruit Count
- 78
- Registration Number
- NCT03430232
- Locations
- 🇳🇱
CHDR, Leiden, Netherlands
News
No news found